卵巢子宫内膜异位恶变的临床分析(2)
[4] Ozols R F， Bookman M A，Connolly D C，et al. Focus on epithelial ovarian cancer[J]. Cancer Cell，2004，10(5):19-24.
[5] Brinton L A， Gridley G， Persson I， et al. Cancer risk after a hospital discharge diagnosis of endometriosis[J]. Am J Obstet Gynecol，1997，152(176):572-579.
[6] Stern R C， Dash R， Bentley R C，et al. Malignancy in endometriosis: Frequency and comparison of ovarian and extraovarian sites[J]. Int J Gynecol Pathol，2001，15(20):133-139.
[7] Pecorelli S， Odicino F， Maisonneuve P， et al. Carcinoma of the ovary[J]. J Epidemiol Biostat，1998，14(3):75-102.
[8] Baxter S W， Thomas E J， Campbell I G. GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer[J]. Carcinogenesis，2001，15(22):63-65.
[9] Fujimura M， Hidaka T， Kataoka K， et al. Absence of estrogen receptor-expression in human ovarian clear cell adenocarcinoma compared with ovarian serous， endometrioid and mucinous adenocarcinoma[J]. Am J Surg Pathol，2001，45(25):667-672.
[10] Obata K， Moreland S J， Watson R H， et al. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors[J]. Cancer Res，1998，45(58):2095-2097.
[11] Dinulescu D M， Ince T A， Quade B J， et al. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer[J]. Nat Med，2005，10(11):63-70.
(收稿日期：2012-03-26) (本文编辑：李嫚), 百拇医药(裴慧琳 于欢)
[5] Brinton L A， Gridley G， Persson I， et al. Cancer risk after a hospital discharge diagnosis of endometriosis[J]. Am J Obstet Gynecol，1997，152(176):572-579.
[6] Stern R C， Dash R， Bentley R C，et al. Malignancy in endometriosis: Frequency and comparison of ovarian and extraovarian sites[J]. Int J Gynecol Pathol，2001，15(20):133-139.
[7] Pecorelli S， Odicino F， Maisonneuve P， et al. Carcinoma of the ovary[J]. J Epidemiol Biostat，1998，14(3):75-102.
[8] Baxter S W， Thomas E J， Campbell I G. GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer[J]. Carcinogenesis，2001，15(22):63-65.
[9] Fujimura M， Hidaka T， Kataoka K， et al. Absence of estrogen receptor-expression in human ovarian clear cell adenocarcinoma compared with ovarian serous， endometrioid and mucinous adenocarcinoma[J]. Am J Surg Pathol，2001，45(25):667-672.
[10] Obata K， Moreland S J， Watson R H， et al. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors[J]. Cancer Res，1998，45(58):2095-2097.
[11] Dinulescu D M， Ince T A， Quade B J， et al. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer[J]. Nat Med，2005，10(11):63-70.
(收稿日期：2012-03-26) (本文编辑：李嫚), 百拇医药(裴慧琳 于欢)